Credit:DavidBGray on iStock What is Equillium all about? We started the company four years ago around our lead drug program itolizumab. My
Equillium CEO Bruce Steel: We are among the few evaluated in first-line GVHD treatment
Categories
Health Care
Rite Aid Corporation (RAD) Q3 2022 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q3 2022 earnings call dated Dec. 21, 2021 Corporate Participants: Trent Kruse -- Senior Vice President of Investor Relations
HEXO Corp. (HEXO) Q1 2022 Earnings Call
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith — Director, Investor Relations Scott Cooper — President, Chief Executive Officer
HEXO Corp. (HEXO) Q1 2022 Earnings Call Transcript
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith -- Director, Investor Relations Scott Cooper -- President, Chief Executive
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris -- President & Chief Executive Officer David
Merck & Co. (MRK) stock research summary | Q3 2021
Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on EPS earning
Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco
Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States. Founded in
Avid Bioservices, Inc. (CDMO) Q2 2022 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons -- Investor Relations, Vida Strategic Partners Nicholas
HealthEquity, Inc. (HQY) Q3 2021 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ: HQY) Q3 2021 earnings call dated Dec. 06, 2021 Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President/Chief Executive Officer Tyson
Eli Lilly and Company (LLY) Earnings: 3Q21 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year. Reported net
IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing
Patterson Companies, Inc. (PDCO) Q2 2022 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q2 2022 earnings call dated Dec. 01, 2021 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript
Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck -- Head of Investor Relations Hermann Luebbert
BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to Bristol Myers
Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript
Centogene N.V. (NASDAQ: CNTG) Q3 2021 earnings call dated Nov. 24, 2021 Corporate Participants: Lennart Streibel -- Investor Relations Andrin Oswald -- Chief Executive Officer Rene
Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective medical procedures
Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Colgate-Palmolive Company (CL) earnings Q3 2021 results
Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for the third
Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also